Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

8.24
-0.4100-4.74%
Post-market: 8.340.0958+1.16%16:57 EDT
Volume:3.08M
Turnover:25.49M
Market Cap:1.41B
PE:-10.30
High:8.56
Open:8.38
Low:8.02
Close:8.65
52wk High:12.06
52wk Low:2.24
Shares:171.61M
Float Shares:156.49M
Volume Ratio:1.24
T/O Rate:1.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7999
EPS(LYR):-0.8421
ROE:-57.72%
ROA:-34.10%
PB:5.75
PE(LYR):-9.78

Loading ...

Absci Shares Fall After 1Q Loss Widens

Dow Jones
·
May 08

Absci Q1 revenue drops, misses estimates

Reuters
·
May 08

Absci Q1 EPS $(0.19) Beats $(0.23) Estimate, Sales $215.000K Miss $1.550M Estimate

Benzinga Earnings
·
May 08

BRIEF-Absci Q1 Pretax Profit USD -29.581 Million

Reuters
·
May 08

Absci publishes corporate presentation on generative AI drug creation platform

Reuters
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Absci Corp expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
May 06

Absci grants 276,200-share stock option at $4.92 under inducement plan

Reuters
·
May 05

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 05

BUZZ-Absci rises as brokerage highlights growing opportunity in hair‑loss market

Reuters
·
Apr 28

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT)

TIPRANKS
·
Apr 01

Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), AbSci (ABSI) and MaxCyte (MXCT)

TIPRANKS
·
Mar 30

Absci Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
Mar 30

Absci Shares Fall 4.9% After Q4 Results

THOMSON REUTERS
·
Mar 25

Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga
·
Mar 25

Absci price target lowered to $4.20 from $4.32 at Morgan Stanley

TIPRANKS
·
Mar 25

Absci Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
Mar 25

AbSci (ABSI) Gets a Buy from Guggenheim

TIPRANKS
·
Mar 25

Absci Corp : Morgan Stanley Cuts Target Price to $4.20 From $4.32

THOMSON REUTERS
·
Mar 25

Analysts Conflicted on These Healthcare Names: Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALNY)

TIPRANKS
·
Mar 25